1962•The Journal of Clinical Endocrinology & MetabolismRequires access

Decreased Adrenal Androgen Biosynthesis in Patients with Gonadal Dysgenesis

Mortimer B. Lipsett

Open publisher page 11 citations

Abstract

The excretion of the 17-ketosteroids, Silber-Porter chromogens, 11-deoxyketosteroids, 11-oxyketosteroids, pregnanetriol, tetrahydro compound S, and Δ6-pregnenetriol was investigated in 4 patients with gonadal dysgenesis, during a control period and after stimulation with ACTH. The results are compared with those obtained in identical studies of 2 young ovariectomized women and a woman with ovarian hypoplasia. In 3 of the 4 patients with gonadal dysgenesis the excretion of 17-ketosteroids was low due to low levels of dehydroepiandrosterone, androsterone and etiocholanolone. The excretion of these steroids did not reach normal levels after three days of ACTH stimulation. The excretion of the 11-oxyketosteroids, 11β-hydroxyetiocholanolone, 11β-hydroxy androsterone, and 11-ketoetiocholanolone was normal. No differences could be demonstrated in the excretion of pregnanetriol, tetrahydro compound S or Δ5-pregnenetriol, either initially or after ACTH. It is concluded that adrenal androgen biosynthesis is decreased in some patients with gonadal dysgenesis. This appears to be in a pathway of androgen bio- Synthesis separate from corticoid biosynthesis. This may represent another of the multiple defects associated with gonadal dysgenesis.

About this research paper

What this paper is about

The excretion of the 17-ketosteroids, Silber-Porter chromogens, 11-deoxyketosteroids, 11-oxyketosteroids, pregnanetriol, tetrahydro compound S, and Δ6-pregnenetriol was investigated in 4 patients with gonadal dysgenesis, during a control period and after stimulation with ACTH. The results are compared with those obtained in identical studies of 2 young ovariectomized women and a woman with ovarian hypoplasia. In 3 of the 4 patients with gonadal dysgenesis the excretion of 17-ketosteroids was low due to low levels of dehydroepiandrosterone, androsterone and etiocholanolone. The excretion of these steroids did not reach normal levels after three days of ACTH stimulation. The excretion of the 11-oxyketosteroids, 11β-hydroxyetiocholanolone, 11β-hydroxy androsterone, and 11-ketoetiocholanolone was normal. No differences could be demonstrated in the excretion of pregnanetriol, tetrahydro compound S or Δ5-pregnenetriol, either initially or after ACTH. It is concluded that adrenal androgen biosynthesis is decreased in some patients with gonadal dysgenesis. This appears to be in a pathway of androgen bio- Synthesis separate from corticoid biosynthesis. This may represent another of the multiple defects associated with gonadal dysgenesis.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The excretion of the 17-ketosteroids, Silber-Porter chromogens, 11-deoxyketosteroids, 11-oxyketosteroids, pregnanetriol, tetrahydro compound S, and Δ6-pregnenetriol was investigated in 4 patients with gonadal dysgenesis, during a control period and after stimulation with ACTH. The results are compared with those obtained in identical studies of 2 young ovariectomized women and a woman with ovarian hypoplasia. In 3 of the 4 patients with gonadal dysgenesis the excretion of 17-ketosteroids was low due to low levels of dehydroepiandrosterone, androsterone and etiocholanolone. The excretion of these steroids did not reach normal levels after three days of ACTH stimulation. The excretion of the 11-oxyketosteroids, 11β-hydroxyetiocholanolone, 11β-hydroxy androsterone, and 11-ketoetiocholanolone was normal. No differences could be demonstrated in the excretion of pregnanetriol, tetrahydro compound S or Δ5-pregnenetriol, either initially or after ACTH. It is concluded that adrenal androgen biosynthesis is decreased in some patients with gonadal dysgenesis. This appears to be in a pathway of androgen bio- Synthesis separate from corticoid biosynthesis. This may represent another of the multiple defects associated with gonadal dysgenesis.

Key concepts: Androsterone, Endocrinology, Internal medicine, Etiocholanolone, Excretion, Dehydroepiandrosterone, Androgen, Stimulation

Related papers

Back to paper searchBrowse research topicsOriginal source
Decreased Adrenal Androgen Biosynthesis in Patients with Gonadal Dysgenesis — Research Paper | ScholarLens